Alexis Borisy

Alexis A. Borisy founded IDRx, Inc. in 2021, CombinatoRx, Inc. in 2000, where he worked as President, Chief Executive Officer & Director from 2000 to 2009, Forma Therapeutics, Inc. in 2007, where he worked as Chairman from 2011 to 2012, Foundation Medicine, Inc. in 2009, where he worked as Independent Director from 2017 to 2018, Blueprint Medicines Corp.
in 2008, where he worked as Independent Director from 2014 to 2025, Relay Therapeutics, Inc. in 2015, where he is working as Chairman from 2017, EQRx International, Inc. in 2020, where he is working as Executive Chairman from 2021, EQRx, Inc. in 2019, where he worked as Executive Chairman from 2021 to 2023, ModeX Therapeutics, Inc. in 2020, where he is working as Independent Director from 2020, and Curie Bio Operations LLC in 2022, where he is working as Chairman from 2022.
Mr. Borisy also founded Sesame Therapeutics, Inc. Mr. Borisy also currently works at Museum of Science, as Co-Chairman, Nextech Invest AG, as Chairman from 2022, Revolution Medicines, Inc., as Lead Independent Director from 2014, Parabilis Medicines, Inc., as Lead Independent Director, and Celsius Therapeutics, Inc., as Director.
Mr. Borisy also formerly worked at Warp Drive Bio, Inc., as Executive Chairman from 2013 to 2018, Biotechnology Innovation Organization, as Director, National Venture Capital Association, as Director, Editas Medicine, Inc., as Independent Director from 2013 to 2018, Magenta Therapeutics, Inc., as Independent Director from 2015 to 2022, Tango Therapeutics Sub, Inc., as Director, Thrive Earlier Detection Corp., as Director, Dascena, Inc., as Director, OPKO Health, Inc., as Independent Director from 2022 to 2024, Tango Therapeutics, Inc., as Lead Independent Director in 2026, and Third Rock Ventures LLC, as Partner from 2010 to 2019.
Mr. Borisy received his undergraduate degree in 1993 from The University of Chicago and graduate degree in 1995 from Harvard University.